AURX
Price
$2.15
Change
+$0.15 (+7.50%)
Updated
Dec 18 closing price
Capitalization
103.37M
Intraday BUY SELL Signals
AVCTF
Price
$0.82
Change
-$0.04 (-4.65%)
Updated
Dec 23 closing price
Capitalization
336.94M
Intraday BUY SELL Signals
Interact to see
Advertisement

AURX vs AVCTF

Header iconAURX vs AVCTF Comparison
Open Charts AURX vs AVCTFBanner chart's image
Nuo Therapeutics
Price$2.15
Change+$0.15 (+7.50%)
Volume$4.28K
Capitalization103.37M
Avacta Group
Price$0.82
Change-$0.04 (-4.65%)
Volume$4K
Capitalization336.94M
AURX vs AVCTF Comparison Chart in %
AURX
Daily Signal:
Gain/Loss:
AVCTF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AURX vs. AVCTF commentary
Dec 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AURX is a Hold and AVCTF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 26, 2025
Stock price -- (AURX: $2.15 vs. AVCTF: $0.82)
Brand notoriety: AURX and AVCTF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AURX: 127% vs. AVCTF: 25%
Market capitalization -- AURX: $103.37M vs. AVCTF: $336.94M
AURX [@Biotechnology] is valued at $103.37M. AVCTF’s [@Biotechnology] market capitalization is $336.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AURX’s FA Score shows that 0 FA rating(s) are green whileAVCTF’s FA Score has 0 green FA rating(s).

  • AURX’s FA Score: 0 green, 5 red.
  • AVCTF’s FA Score: 0 green, 5 red.
According to our system of comparison, both AURX and AVCTF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AURX’s TA Score shows that 5 TA indicator(s) are bullish while AVCTF’s TA Score has 4 bullish TA indicator(s).

  • AURX’s TA Score: 5 bullish, 3 bearish.
  • AVCTF’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, AURX is a better buy in the short-term than AVCTF.

Price Growth

AURX (@Biotechnology) experienced а +7.50% price change this week, while AVCTF (@Biotechnology) price change was -26.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.88%. For the same industry, the average monthly price growth was +4.46%, and the average quarterly price growth was +55.39%.

Industries' Descriptions

@Biotechnology (+2.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVCTF($337M) has a higher market cap than AURX($103M). AURX YTD gains are higher at: 53.571 vs. AVCTF (44.265).
AURXAVCTFAURX / AVCTF
Capitalization103M337M31%
EBITDA-2.42MN/A-
Gain YTD53.57144.265121%
P/E RatioN/AN/A-
Revenue2.61MN/A-
Total Cash515KN/A-
Total Debt115KN/A-
FUNDAMENTALS RATINGS
AURX: Fundamental Ratings
AURX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
PROFIT vs RISK RATING
1..100
68
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AURXAVCTF
RSI
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
38%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
45%
Momentum
ODDS (%)
Bullish Trend 3 days ago
67%
Bearish Trend 3 days ago
48%
MACD
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
50%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
72%
Bearish Trend 3 days ago
40%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
72%
Bearish Trend 3 days ago
35%
Advances
ODDS (%)
Bullish Trend 29 days ago
77%
Bullish Trend 22 days ago
50%
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
30%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
13%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
AURX
Daily Signal:
Gain/Loss:
AVCTF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JCVVX19.800.11
+0.56%
JHancock Classic Value R5
PMVQX27.920.07
+0.25%
PGIM Quant Solutions Mid-Cap Val R6
ODIIX137.680.09
+0.07%
Invesco Discovery R6
VSQSX15.350.01
+0.07%
Invesco MSCI World SRI Index R6
FDVAX27.69-0.01
-0.04%
Fidelity Advisor Diversified Intl A

AURX and

Correlation & Price change

A.I.dvisor tells us that AURX and ALZN have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AURX and ALZN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AURX
1D Price
Change %
AURX100%
N/A
ALZN - AURX
30%
Poorly correlated
-1.12%
VRAX - AURX
27%
Poorly correlated
+5.69%
NCNA - AURX
26%
Poorly correlated
+0.91%
FENC - AURX
23%
Poorly correlated
+0.39%
QNCX - AURX
22%
Poorly correlated
-0.27%
More

AVCTF and

Correlation & Price change

A.I.dvisor tells us that AVCTF and KZIA have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AVCTF and KZIA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVCTF
1D Price
Change %
AVCTF100%
N/A
KZIA - AVCTF
26%
Poorly correlated
-6.76%
PHMMF - AVCTF
20%
Poorly correlated
N/A
BETRF - AVCTF
15%
Poorly correlated
-17.59%
AURX - AVCTF
11%
Poorly correlated
N/A
BPMUF - AVCTF
9%
Poorly correlated
N/A
More